Avanos Medical, Inc. (NYSE:AVNS) Shares Sold by Arrowstreet Capital Limited Partnership

Arrowstreet Capital Limited Partnership cut its position in shares of Avanos Medical, Inc. (NYSE:AVNS - Free Report) by 43.0% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 259,417 shares of the company's stock after selling 195,514 shares during the period. Arrowstreet Capital Limited Partnership owned about 0.56% of Avanos Medical worth $4,130,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds have also made changes to their positions in the company. Illinois Municipal Retirement Fund increased its holdings in Avanos Medical by 3.1% during the fourth quarter. Illinois Municipal Retirement Fund now owns 25,236 shares of the company's stock valued at $402,000 after buying an additional 748 shares during the period. Quarry LP purchased a new position in shares of Avanos Medical in the 3rd quarter valued at $42,000. US Bancorp DE raised its position in shares of Avanos Medical by 18.0% in the 4th quarter. US Bancorp DE now owns 14,093 shares of the company's stock worth $224,000 after acquiring an additional 2,147 shares in the last quarter. New York State Teachers Retirement System lifted its stake in shares of Avanos Medical by 4.0% during the 4th quarter. New York State Teachers Retirement System now owns 75,215 shares of the company's stock worth $1,197,000 after purchasing an additional 2,921 shares during the last quarter. Finally, Quantbot Technologies LP bought a new stake in Avanos Medical during the fourth quarter valued at about $64,000. 95.17% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Separately, StockNews.com upgraded shares of Avanos Medical from a "hold" rating to a "buy" rating in a report on Wednesday, March 19th.

Insider Activity at Avanos Medical

In other Avanos Medical news, SVP Kerr Holbrook sold 7,000 shares of the stock in a transaction dated Thursday, March 6th. The stock was sold at an average price of $15.25, for a total transaction of $106,750.00. Following the sale, the senior vice president now directly owns 82,047 shares of the company's stock, valued at approximately $1,251,216.75. This trade represents a 7.86 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 2.64% of the stock is owned by insiders.

Avanos Medical Stock Performance

AVNS stock traded up $0.10 during trading on Monday, reaching $12.57. The company had a trading volume of 15,712 shares, compared to its average volume of 323,525. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.46 and a current ratio of 2.22. Avanos Medical, Inc. has a twelve month low of $12.09 and a twelve month high of $25.36. The company has a market cap of $578.30 million, a price-to-earnings ratio of 36.86 and a beta of 1.15. The firm has a 50-day simple moving average of $14.86 and a 200-day simple moving average of $17.45.

Avanos Medical (NYSE:AVNS - Get Free Report) last announced its quarterly earnings data on Wednesday, February 26th. The company reported $0.43 earnings per share for the quarter, beating analysts' consensus estimates of $0.40 by $0.03. Avanos Medical had a net margin of 2.30% and a return on equity of 4.70%. The firm had revenue of $179.60 million for the quarter, compared to analyst estimates of $177.23 million. As a group, sell-side analysts expect that Avanos Medical, Inc. will post 1.32 earnings per share for the current year.

Avanos Medical Profile

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.